Pharmaceutical company.
National Defense Authorization Act for FY2024 & FY2025, provisions related to biological and chemical defense and access to naloxone. Increasing access to Naloxone. FAA reauthorization - increasing access to naloxone. S. 2333, Pandemic and All-Hazards Preparedness and Response Act. H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. Funding for medical countermeasure enterprise including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY2024 & FY2025. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY2024 & FY2025. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
DEF - Defense AVI - Aviation/Airlines/Airports AER - Aerospace HCR - Health Issues BUD - Budget/Appropriations
1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
DONALD KENT DONALD KENT DONALD KENT GREG D'ANGELO MARY BETH SAVARY TAYLOR DONALD KENT DONALD KENT